USA - New York Stock Exchange - NYSE:CTEV - US62548M2098 - Common Stock
The current stock price of CTEV is 33.89 USD. In the past month the price decreased by -15.17%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 28.36 | 36.08B | ||
| DOCS | DOXIMITY INC-CLASS A | 26.4 | 8.15B | ||
| WAY | WAYSTAR HOLDING CORP | 23.41 | 6.00B | ||
| HTFL | HEARTFLOW INC | N/A | 2.47B | ||
| CERT | CERTARA INC | 17.48 | 1.39B | ||
| SDGR | SCHRODINGER INC | N/A | 1.32B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.25B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.12B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 650 | 1.10B | ||
| PHR | PHREESIA INC | N/A | 976.53M | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 7.86 | 933.43M | ||
| HSTM | HEALTHSTREAM INC | 33.51 | 676.18M |
Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.
CLARITEV CORP
7900 Tysons One Place, Suite 400
McLean VIRGINIA US
Employees: 2700
Phone: 12127802000
Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.
The current stock price of CTEV is 33.89 USD. The price decreased by -20.73% in the last trading session.
CTEV does not pay a dividend.
CTEV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
CLARITEV CORP (CTEV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-20.48).
CLARITEV CORP (CTEV) has a market capitalization of 560.20M USD. This makes CTEV a Small Cap stock.
The outstanding short interest for CLARITEV CORP (CTEV) is 8.59% of its float.
ChartMill assigns a fundamental rating of 2 / 10 to CTEV. Both the profitability and financial health of CTEV have multiple concerns.
Over the last trailing twelve months CTEV reported a non-GAAP Earnings per Share(EPS) of -20.48. The EPS increased by 67.52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.85% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
9 analysts have analysed CTEV and the average price target is 90.1 USD. This implies a price increase of 165.86% is expected in the next year compared to the current price of 33.89.
For the next year, analysts expect an EPS growth of 76.22% and a revenue growth 2.91% for CTEV